Product image of Methadone Martindale Pharma (Methadone Hydrochloride) supplied by GNH India

Methadone Martindale Pharma

Active Ingredient:
Methadone Hydrochloride
Origin:
EU

Methadone Martindale Pharma (Methadone Hydrochloride)

Methadone Hydrochloride, the active ingredient in Methadone Martindale Pharma, is a synthetic opioid presented as an oral formulation for oral use. It treats moderate to severe chronic pain and is used in opioid dependence maintenance therapy.

GNH India supplies Methadone Martindale Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Martindale Pharmaceuticals Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methadone acts on the opioid system to provide analgesia and to support opioid substitution therapy.

  • Moderate to severe chronic pain: provides long‑acting analgesia for patients with persistent pain.
  • Opioid dependence: stabilises opioid receptors to reduce withdrawal symptoms and cravings.
  • Palliative care: manages severe pain in end‑of‑life settings.

How It Works

  • Methadone Hydrochloride is a full agonist at the mu‑opioid receptor, producing analgesia by decreasing neuronal excitability and altering pain perception. It also blocks NMDA receptors and inhibits reuptake of serotonin and norepinephrine, contributing to its efficacy in opioid dependence maintenance and chronic pain control.

Side Effects

Methadone may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Constipation: reduced bowel motility.
  • Dizziness: sensation of light‑headedness.
  • Sedation: increased sleepiness.

Serious or Rare Side Effects

  • Respiratory depression: slowed breathing, potentially fatal.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe hypotension: marked drop in blood pressure.
  • Anaphylaxis: rare allergic reaction requiring immediate care.

Precautions & Warnings

Methadone requires careful monitoring due to its potency and pharmacologic profile.

  • Dose titration: adjust gradually under medical supervision to minimise overdose risk.
  • Respiratory monitoring: observe for depression, especially in opioid‑naïve patients.
  • Cardiac assessment: obtain baseline ECG to evaluate QT interval.
  • Dependence potential: assess patient history for substance‑use disorder.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methadone interacts with several drug classes that can alter its safety or efficacy.

Major Interactions (Avoid)

  • CNS depressants: may cause profound sedation and respiratory depression.
  • QT‑prolonging agents: increase risk of cardiac arrhythmias.
  • MAO inhibitors: can precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • SSRIs and SNRIs: may enhance serotonergic effects.
  • CYP3A4 inducers (e.g., carbamazepine): can reduce methadone plasma levels.
  • CYP3A4 inhibitors (e.g., erythromycin): may increase methadone concentrations.
  • Anticonvulsants: may require dose adjustments.

Frequently Asked Questions

Methadone Martindale Pharma contains methadone hydrochloride, a synthetic opioid indicated for the management of moderate to severe chronic pain and for maintenance therapy in patients with opioid dependence. It helps control persistent pain and reduces withdrawal symptoms in individuals undergoing opioid substitution programs.

Methadone acts as a full agonist at the mu‑opioid receptors, decreasing neuronal excitability and altering the perception of pain. It also blocks NMDA receptors and inhibits the reuptake of serotonin and norepinephrine, which contributes to its effectiveness in both analgesia and opioid dependence treatment.

The appropriate dose of methadone is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosing regimens vary widely, and adjustments are made under close medical supervision.

Safety data for methadone in pregnancy and lactation are limited, and the drug should only be used when the potential benefit justifies the potential risk to the fetus or infant. Clinicians typically weigh the risks of untreated opioid dependence against possible drug effects and monitor both mother and child closely.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required cold‑chain handling), and import documentation.

Methadone is a long‑acting full mu‑opioid receptor agonist, offering once‑daily dosing for many patients, whereas alternatives such as buprenorphine are partial agonists with a ceiling effect on respiratory depression. Methadone’s pharmacokinetic profile provides stable plasma levels, but it requires careful monitoring for cardiac and respiratory side effects.

Methadone should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product in a dry, well‑ventilated area helps maintain its stability and potency throughout its shelf life.

Methadone is administered orally, typically as a tablet or liquid formulation. The exact route and dosage form depend on the prescribing information and the patient’s needs. Administration should follow the prescriber’s instructions, and the medication should be taken with or without food as directed.

The most serious risks include respiratory depression, especially in opioid‑naïve individuals or when combined with other CNS depressants, and cardiac arrhythmias due to QT interval prolongation. Patients should be monitored for signs of severe sedation, breathing difficulties, and cardiac abnormalities, and any concerning symptoms should prompt immediate medical evaluation.

Methadone is contraindicated in individuals with known hypersensitivity to methadone or any of its excipients, those with severe respiratory insufficiency, uncontrolled asthma, or significant cardiac conduction disorders. Caution is also advised for patients with a history of substance misuse, as methadone carries a risk of dependence and abuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.